APA (7th ed.) Citation

Mori, Y., Izumiyama, T., Kurishima, H., Kamimura, M., Baba, K., Mori, N., & Itoi, E. (2021). Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodies. Journal of Orthopaedic Surgery & Research, 16(1), 1. https://doi.org/10.1186/s13018-021-02271-2

Chicago Style (17th ed.) Citation

Mori, Yu, Takuya Izumiyama, Hiroaki Kurishima, Masayuki Kamimura, Kazuyoshi Baba, Naoko Mori, and Eiji Itoi. "Effect of Denosumab Switched from Bisphosphonates in Preventing Joint Destruction in Postmenopausal Rheumatoid Arthritis Patients with Anti-cyclic Citrullinated Peptide Antibodies." Journal of Orthopaedic Surgery & Research 16, no. 1 (2021): 1. https://doi.org/10.1186/s13018-021-02271-2.

MLA (9th ed.) Citation

Mori, Yu, et al. "Effect of Denosumab Switched from Bisphosphonates in Preventing Joint Destruction in Postmenopausal Rheumatoid Arthritis Patients with Anti-cyclic Citrullinated Peptide Antibodies." Journal of Orthopaedic Surgery & Research, vol. 16, no. 1, 2021, p. 1, https://doi.org/10.1186/s13018-021-02271-2.